Reviewed by the PeptideMind Team · Updated July 15, 2026

Abaloparatide Dosage Guide, Benefits & Side Effects

FDA-approved Abaloparatide activates PTH1R to rebuild bone density and cut vertebral fracture risk. See dosing, mechanism, and trial results.

Chemical Makeup

34

Amino Acids

Abaloparatide

Ala

A

Position 1

Val

V

Position 2

Ser

S

Position 3

Glu

E

Position 4

His

H

Position 5

Gln

Q

Position 6

Leu

L

Position 7

Leu

L

Position 8

His

H

Position 9

Asp

D

Position 10

Lys

K

Position 11

Gly

G

Position 12

Lys

K

Position 13

Ser

S

Position 14

Ile

I

Position 15

Gln

Q

Position 16

Asp

D

Position 17

Leu

L

Position 18

Arg

R

Position 19

Arg

R

Position 20

Arg

R

Position 21

Glu

E

Position 22

Leu

L

Position 23

Leu

L

Position 24

Glu

E

Position 25

Lys

K

Position 26

Leu

L

Position 27

Leu

L

Position 28

?

X

Position 29

Lys

K

Position 30

Leu

L

Position 31

His

H

Position 32

Thr

T

Position 33

Ala

A

Position 34

Amino acid sequence
AlaninePosition 1
ValinePosition 2
SerinePosition 3
Glutamic acidPosition 4
HistidinePosition 5
GlutaminePosition 6
LeucinePosition 7
LeucinePosition 8
HistidinePosition 9
Aspartic acidPosition 10
LysinePosition 11
GlycinePosition 12
LysinePosition 13
SerinePosition 14
IsoleucinePosition 15
GlutaminePosition 16
Aspartic acidPosition 17
LeucinePosition 18
ArgininePosition 19
ArgininePosition 20
ArgininePosition 21
Glutamic acidPosition 22
LeucinePosition 23
LeucinePosition 24
Glutamic acidPosition 25
LysinePosition 26
LeucinePosition 27
LeucinePosition 28
?Position 29
LysinePosition 30
LeucinePosition 31
HistidinePosition 32
ThreoninePosition 33
AlaninePosition 34

As seen on

American PressStreet InsiderBusiness InsiderBenzingaCBSYahoo Finance

Abaloparatide Dosage Guide for Bone Health & Density

Abaloparatide (Tymlos) is an FDA-approved peptide drug that signals bone-building cells to work harder, helping raise bone density and lower fracture risk. It comes in a prefilled pen, given as a daily injection, often alongside calcium and vitamin D, for osteoporosis rather than general research use. Comes pre-mixed in a ready-to-use prefilled pen — no reconstitution needed.

Vial size

3,120 mcg/1.56 mL prefilled pen (2,000 mcg/mL)

Bacteriostatic water

N/A

Dosing

80 mcg per injection

Frequency

Daily

Cycle

Up to 24 months (lifetime maximum)

Benefit

Bone Health & Density

Explore calculators

What is Abaloparatide?

Abaloparatide (brand name Tymlos) is an FDA-approved medication that helps the body build new, stronger bone. It's given as a daily injection to people, mostly postmenopausal women but also some men, who are at high risk of breaking a bone due to osteoporosis. Because of how it works, it's only meant to be used for up to two years in a lifetime.

Healing

Research targets include tissue repair, wound healing, and recovery from injury.

Healing

aba

Is Abaloparatide FDA approved?

Abaloparatide is FDA approved.

FDA Approved

Abaloparatide has been reviewed and approved by the FDA for safety and efficacy in its approved indications.

Regulated Manufacturing

Manufactured under FDA-regulated quality standards, ensuring consistent purity and dosing.

Prescription Use

Legally available by prescription for its approved medical indications.

A smartphone screen displaying an app interface labeled "FDA Status," confirming a drug's approval status with a green "Yes" indicator. Below, there is an "Approved Use" section highlighting FDA approval, accompanied by usage instructions and additional information about the importance of regulatory approval for drug safety and effectiveness.

Our top-rated vendor

View all

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health logo

Protide Health

#1 Rated Research Peptide Supplier

How Does Abaloparatide Work?

It attaches to a bone-signaling receptor in a way that produces a short, sharp burst of activity rather than a constant one. That brief signal tips the balance toward cells that build new bone rather than cells that break bone down, so the net effect is bone gain.

Binds bone receptors

Attaches to the PTH1 receptor on bone-forming cells.

Short, sharp signal

Produces a brief burst of activity instead of a constant one.

Builds new bone

Tips the balance toward bone formation over breakdown.

Abaloparatide Targeted areas

How to reconstitute Abaloparatide

View guide

The materials you'll need and step-by-step instructions for safely mixing Abaloparatide with bacteriostatic water.

Materials needed

Your Abaloparatide vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

1

Remove the caps

Remove the caps from both your Abaloparatide vial and your bacteriostatic water vial.
2

Sanitize the rubber stoppers

Wipe down the rubber stoppers on both vials with alcohol swabs and let them dry for about 3 minutes.
3

Attach the needle

Take your 3 mL syringe and needle. Twist the needle's plastic hub into the Luer Lock tip on the syringe to secure it.
4

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

How much bac water? Abaloparatide typically comes in a 3,120 mcg/1.56 mL prefilled pen (2,000 mcg/mL) vial. We recommend N/A of bacteriostatic water, though anywhere between 1 mL and 3 mL is acceptable. For larger vials you can use up to 5 mL — more bac water makes microdosing easier, but insulin needles usually max out at 1 mL per injection. That means a lot of bac water might force you into multiple injections to hit your target dose. Unless you're microdosing, 2 mL per vial is a solid rule of thumb.
5

Insert the needle into the Abaloparatide vial

With the bac water in your syringe, insert the needle into the Abaloparatide vial at a slight angle to avoid pressure buildup.

Use a thin needle: Stick to 25G or higher to avoid damaging the rubber stopper. Higher gauge means a thinner needle.
6

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Heads up: Sometimes the plunger pushes itself in as soon as the needle enters the vial. Hold the plunger back so you have full control over how fast the bac water enters.
7

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Be patient: This usually takes 2 to 5 minutes of consistent swirling, mixing in a circular motion, and gently flipping the vial up and down. The water needs to run through the powder many times to fully dissolve it. Don't shake or get aggressive with it.
8

Check for full dissolution

The solution should be clear with no visible particles. If it's cloudy or clumpy, wait a minute and repeat the swirling step.
9

Cap, dispose, and store

Once you're done, cap the needle and dispose of it (ideally in a sharps container). Store the reconstituted Abaloparatide vial in the fridge whenever it's not in use. It will stay good for approximately 30 days.

How to Store Abaloparatide

Pre-filled pens should be refrigerated before use, then can sit at room temperature for up to a month once you start using them. As a research powder, keep it frozen long-term and refrigerate briefly once it's mixed with liquid.

Commercial Pen (Tymlos)

Refrigerate at 2–8°C before first use; after first use, store at room temperature (20–25°C) for up to 30 days.

Research Powder

Store at -20°C long-term.

Reconstituted Storage

2–8°C short-term.

A smartphone displaying a "Storage Guide" for peptides, indicating a safe storage temperature range of 2–8°C, with warnings to keep away from light, heat, and freezing. The background is light blue, and additional tips on protecting the peptides are visible below the temperature range.

What Are the Benefits of Abaloparatide?

What research says it may help with, and how it works in the body.

osteoporosis fdaapproved

Approved by the FDA for postmenopausal women with osteoporosis who have a high risk of bone fractures or haven't responded to other treatments.

Approved by the FDA for men with osteoporosis who have a high fracture risk or can't tolerate other treatments.

bone health research

Large late-stage clinical trials showed it substantially reduced fractures, both in the spine and elsewhere in the body.

A clinical trial called ACTIVExtend showed that taking this drug first, then switching to another osteoporosis drug (alendronate), kept bones protected over the long term.

What Are the Side Effects of Abaloparatide?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Paget's disease of bone

Prior external beam or implant radiation therapy to skeleton

Bone metastases or history of skeletal malignancies

Metabolic bone diseases other than osteoporosis

Pre-existing hypercalcemia

Pregnancy or nursing

Cumulative use exceeding 2 years lifetime

Stop Right Away If You Notice

Signs of hypercalcemia (confusion, fatigue, excessive thirst)

Persistent bone pain

Severe dizziness or fainting

Allergic reactions

Milder Signs to Watch For

Cloudy or discolored solutionParticulates visibleExposed to freezing or high temperaturesDamaged pen device
Was it helpful?Yes
No

How Long Should a Abaloparatide Cycle Last?

This breaks down how long a typical Abaloparatide cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Month 1-3
Bone formation markers increase; initial BMD changes begin
Month 3-6
Significant BMD increases at spine, hip, and femur
Month 6-12
Continued bone density improvements; fracture risk reduction
Month 12-18
Maximum benefits in ACTIVE trial; substantial fracture reduction
Month 18-24
Transition to maintenance therapy (e.g., bisphosphonates) recommended

Abaloparatide Research References

It is a fda approved compound

4Research references

Abaloparatide

Abaloparatide is a fda approved compound

ACTIVExtend Trial: Abaloparatide Followed by Alendronate

18 months abaloparatide followed by alendronate significantly reduced vertebral and nonvertebral fractures.

n.d.

Phase 2 Dose-finding Study of BA058 in Postmenopausal Women

Significant BMD increases at 40 and 80 mcg doses; abaloparatide showed superior anabolic effects on hips vs teriparatide.

n.d.

Profile of Abaloparatide and Its Potential in Postmenopausal Osteoporosis

Abaloparatide preferentially binds RG conformational state of PTH1R, producing more anabolic bone effects.

n.d.

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis (ACTIVE Trial)

Abaloparatide showed substantial reduction in vertebral fractures and greater BMD increases at spine, hip, and femur compared to placebo and teriparatide.

n.d.

Frequently Asked Questions About Abaloparatide

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.